Report cover image

Global Veterinary Pharmacovigilance Market Size Study, By Solution (Software, Services), By Type (In-house, Contract Outsourcing), By Product (Biologics, Anti-Infective, Others), By Animal Type (Dogs, Cats, Other Animal Types), And Regional Forecasts 2022

Publisher Bizwit Research & Consulting
Published Mar 10, 2025
Length 285 Pages
SKU # BIZW19841747

Description

The Global Veterinary Pharmacovigilance Market was valued at USD 804.49 million in 2023 and is projected to expand at a CAGR of 13.6% from 2024 to 2032, reaching USD 2534.69 million by 2032. This rapid expansion is driven by increasing veterinary drug approvals, growing awareness about veterinary pharmacovigilance reporting, stricter regulatory compliance requirements, and public and private initiatives to ensure drug safety for animals.

The rising pet ownership, increasing demand for advanced veterinary medicines, and growing investments in pharmacovigilance technologies are further propelling market growth. The emphasis on adverse event monitoring, signal detection, and post-market surveillance of veterinary drugs has become paramount, leading to the adoption of pharmacovigilance software solutions and services. Furthermore, regulatory authorities worldwide are imposing stricter guidelines for veterinary drug approvals and pharmacovigilance inspections, ensuring the safety and efficacy of veterinary pharmaceuticals.

The integration of artificial intelligence (AI), data analytics, and machine learning (ML) in veterinary pharmacovigilance is playing a pivotal role in enhancing the accuracy and efficiency of adverse event monitoring. AI-powered pharmacovigilance software enables real-time detection and reporting of adverse drug reactions (ADRs) and medication errors, helping veterinary pharmaceutical companies comply with evolving regulations. For instance, in 2024, the World Health Organization (WHO) expanded its International Drug Monitoring Programme, reflecting a global commitment to strengthening pharmacovigilance systems. Similarly, the European Union (EU) has intensified its focus on continuous signal management to ensure the safety of veterinary medicinal products.

From a regional perspective, North America dominated the veterinary pharmacovigilance market in 2024, holding a 40.0% revenue share, primarily due to well-established veterinary healthcare infrastructure, stringent regulatory guidelines, and the presence of leading pharmacovigilance service providers. The Asia-Pacific region is expected to grow at the fastest CAGR of 15.4%, fueled by rising pet ownership, increasing government regulations on veterinary drug safety, and expanding veterinary healthcare investments in countries like China, India, and Japan.

Major Market Players Included in This Report:
• ArisGlobal
• Accenture
• Ennov
• Sarjen Systems Pvt. Ltd.
• Pharsafer Associates Limited
• Knoell
• Biologit
• Indivirtus
• Azierta Contract Science Support Consulting
• Oy Medfiles Ltd.

The Detailed Segments and Sub-Segment of the Market Are Explained Below:

By Solution:
• Software
• Services

By Type:
• In-house
• Contract Outsourcing

By Product:
• Biologics
• Anti-Infective
• Other Products

By Animal Type:
• Dogs
• Cats
• Other Animal Types

By Region:

North America
• U.S.
• Canada
• Mexico

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Thailand
• Rest of Asia Pacific

Latin America
• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Rest of Middle East & Africa

Years Considered for the Study:
• Historical Year – 2022
• Base Year – 2023
• Forecast Period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years (2022-2032)
• Annualized Revenue and Regional-Level Analysis for each market segment
• Geographical Breakdown with country-level market evaluations
• Competitive Landscape Analysis with information on major market players
• Insights into Key Business Strategies, Growth Drivers, and Challenges
• Supply & Demand Side Analysis of the market

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

285 Pages
Chapter 1. Global Vials and Ampoules Market Executive Summary
1.1. Global Vials and Ampoules Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Material
1.3.2. By End Use Industry
1.3.3. By Product
1.3.4. By Size
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Vials and Ampoules Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Vials and Ampoules Market Dynamics
3.1. Market Drivers
3.1.1. Increasing demand for biologics and vaccines
3.1.2. Advancements in pharmaceutical packaging technology
3.1.3. Rising pharmaceutical R&D and investments in healthcare infrastructure
3.2. Market Challenges
3.2.1. High cost of raw materials for vials and ampoules manufacturing
3.2.2. Concerns over sustainability and environmental impact of pharmaceutical packaging
3.3. Market Opportunities
3.3.1. Growth of healthcare infrastructure in emerging economies
3.3.2. Development of smart packaging and RFID-enabled vials and ampoules
3.3.3. Increasing use of eco-friendly packaging materials
Chapter 4. Global Vials and Ampoules Market Industry Analysis
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Five Forces Model
4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic Factors
4.2.3. Social Factors
4.2.4. Technological Factors
4.2.5. Environmental Factors
4.2.6. Legal Factors
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends in the Vials and Ampoules Industry
4.6. Industry Expert Perspectives
4.7. Analyst Recommendations & Conclusion
Chapter 5. Global Vials and Ampoules Market Size & Forecasts by Material (2022-2032)
5.1. Segment Dashboard
5.2. Global Vials and Ampoules Market: Material Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Glass
5.2.2. Plastic
Chapter 6. Global Vials and Ampoules Market Size & Forecasts by End Use Industry (2022-2032)
6.1. Segment Dashboard
6.2. Global Vials and Ampoules Market: End Use Industry Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Pharmaceutical
6.2.2. Food & Beverage
6.2.3. Chemical
6.2.4. Personal Care & Cosmetics
Chapter 7. Global Vials and Ampoules Market Size & Forecasts by Product (2022-2032)
7.1. Segment Dashboard
7.2. Global Vials and Ampoules Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Vials
7.2.2. Ampoules
Chapter 8. Global Vials and Ampoules Market Size & Forecasts by Size (2022-2032)
8.1. Segment Dashboard
8.2. Global Vials and Ampoules Market: Size Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.2.1. Small
8.2.2. Large
Chapter 9. Global Vials and Ampoules Market Size & Forecasts by Region (2022-2032)
9.1. North America Vials and Ampoules Market
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2. Europe Vials and Ampoules Market
9.2.1. Switzerland
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. UK
9.3. Asia-Pacific Vials and Ampoules Market
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Australia
9.4. Latin America Vials and Ampoules Market
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Colombia
9.5. Middle East & Africa Vials and Ampoules Market
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. South Africa
Chapter 10. Research Process
10.1. Research Process Overview
10.2. Data Collection & Sources
10.3. Primary Research Approach
10.4. Secondary Research Approach
10.5. Market Estimation Techniques
10.6. Data Validation & Triangulation
10.7. Assumptions & Limitations
10.8. Publishing Process
10.9. Research Attributes
10.10. Disclaimer
List of Tables
TABLE 1. Global Vials and Ampoules Market, Report Scope
TABLE 2. Global Vials and Ampoules Market Estimates & Forecasts by Region 2022-2032 (USD Million)
TABLE 3. Global Vials and Ampoules Market Estimates & Forecasts by Material 2022-2032 (USD Million)
TABLE 4. Global Vials and Ampoules Market Estimates & Forecasts by End Use Industry 2022-2032 (USD Million)
TABLE 5. Global Vials and Ampoules Market Estimates & Forecasts by Product 2022-2032 (USD Million)
TABLE 6. Global Vials and Ampoules Market Estimates & Forecasts by Size 2022-2032 (USD Million)
This list is not complete. The final report contains more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIGURE 1. Global Vials and Ampoules Market Research Methodology
FIGURE 2. Market Revenue Trends by Material
FIGURE 3. Market Revenue Trends by End Use Industry
FIGURE 4. Regional Market Breakdown
FIGURE 5. Competitive Positioning of Key Market Players
This list is not complete. The final report contains more than 50 figures. The list may be updated in the final deliverable.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us